peptide-camptothecin conjugates (Sigma-Tau)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namepeptide-camptothecin conjugates (Sigma-Tau)
Drug Alias NameST-3833ST-4215ST-3280ST-4167ST-2724 +[7] 
ClassificationSmall molecules
Mechanisms of ActionDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSigma-Tau Industrie Farmaceutiche Riunite Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSigma-Tau Industrie Farmaceutiche Riunite Spa
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A